|
|
|
Volumn 25, Issue 5, 2012, Pages 30-33
|
|
Optimizing drug delivery for modern biologics
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
ADALIMUMAB;
BIOLOGICAL PRODUCT;
CERTOLIZUMAB PEGOL;
GOLIMUMAB;
MONOCLONAL ANTIBODY;
ARTICLE;
CHRONIC DISEASE;
CROHN DISEASE;
DRUG APPROVAL;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INDICATION;
DRUG MEGADOSE;
DRUG QUALITY;
DRUG SAFETY;
DRUG SELF ADMINISTRATION;
DRUG SOLUTION;
GRAFT REJECTION;
HUMAN;
LOW DRUG DOSE;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL TECHNOLOGY;
MULTIPLE SCLEROSIS;
PHARMACEUTICAL CARE;
PHYSICAL CHEMISTRY;
PILL;
PSORIASIS;
QUALITY CONTROL;
RHEUMATOID ARTHRITIS;
|
|
EID: 84864762825
PISSN: 1542166X
EISSN: 19391862
Source Type: Trade Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
